Preeclampsia (PE) is a major cause of maternal and perinatal mortality, especially in developing countries. Its etiology involves multiple factors, but no specific cause has been identified. Evidence suggests that clinical manifestations are caused by endothelial dysfunction. Nitric oxide (NO), which is synthesized from L-arginine in endothelial cells by the endothelial nitric oxide synthase (eNOS), provides a tonic dilator tone and regulates the adhesion of white blood cells and platelet aggregation. Alterations in the L-arginine-NO pathway have been associated with the development of PE. Various studies, reporting decreased, elevated or unchanged levels of nitrite (NO2) and nitrate (NO3), two end products of NO metabolism, have been published. Our group contributed to those contradictory reports describing cases of PE with both elevated and decreased levels of NO2 and NO3. Apparently, diminished levels of NO could be related to deficiencies in the ingestion of dietary calcium associated to low levels of plasma ionic calcium, which is crucial to the eNOS' activity. Also, low levels of NO could be associated with the presence of eNOS polymorphisms or the presence of increased levels of ADMA, the endogenous inhibitor of NO. High levels of NO associated to low levels of cGMP suggest a decreased bioactivity of NO, which is probably related to an increased degradation of NO caused by a high production of superoxide in states of infection and inflammation. The present article analyses and reviews the reported paradoxical roles of the L-arginine-NO pathway in PE and gives a possible explanation for these results.
Alexander, B.T. , Llinas, M.T. , Kruckeberg, W.C. and Granger, J.P. (2004) L-Arginine attenuates hypertension in pregnant rats with reduced uterine perfusion pressure . Hypertension43: 832-836.
2.
Aydin, S. , Benian, A. , Madazli, R. , Uludag, S. , Uzun, H. and Kaya, S. (2004) Plasma malondialdehyde, superoxide dismutase, sE-selectin, fibronectin, endothelin-1 and nitric oxide levels in women with preeclampsia . Eur J Obstet Gynecol Reprod Biol113: 21-25.
3.
Baksu, B. , Davas, I. , Baksu, A. , Akyol, A. and Gulbaba, G. (2005) Plasma nitric oxide, endothelin-1 and urinary nitric oxide and cyclic guanosine monophosphate levels in hypertensive pregnant women . Int J Gynaecol Obstet90: 112-117.
4.
Baylis, C. , Beinder, E. , Suto, T. and August, P. (1998) Recent insights into the roles of nitric oxide and renin-angiotensin in the pathophysiology of preeclamptic pregnancy . Semin Nephrol18: 208-230.
5.
Begum, S. , Yamasaki, M. and Mochizuki, M. (1996) Urinary levels of nitric oxide metabolites in normal pregnancy and preeclampsia . J Obstet Gynaecol Res22: 551-559.
6.
Berkowitz, D.E. , White, R. , Li, D. , Minhas, K.M. , Cernetich, A. , Kim, S. et al. Arginase reciprocally regulates nitric oxide synthase activity and contributes to endothelial dysfunction in aging blood vessels . Circulation108: 2000-2006.
7.
Biri, A. , Bozkurt, N. , Gunaydin, G. , Korucuoglu, U. , Durak, I. and Kavutcu, M. (2007) Antioxidant enzyme activities and lipid peroxidation in preeclampsia . Int J Gynaecol Obstet96: 196-197.
8.
Brockelsby, J. , Hayman, R. , Ahmed, A. , Warren, A. , Johnson, I. and Baker, P. (1999) VEGF via VEGF receptor-1 (Flt-1) mimics preeclamptic plasma in inhibiting uterine blood vessel relaxation in pregnancy: implications in the pathogenesis of preeclampsia . Lab Invest79: 1101-1111.
9.
Celik, O. , Hascalik, S. and Turkoz,Y. (2003) cFN and NO levels as indexes of endothelial damage in pre-eclampsia . Int J Gynaecol Obstet81: 51-52.
10.
Celik, O. , Hascalik, S. , Turkoz, Y. , Hascalik, M. and Gokdeniz, R. (2003) Cerebrospinal fluid nitric oxide level changes in preeclampsia . Eur J Obstet Gynecol Reprod Biol111: 141-145.
11.
Chamy, V.M. , Lepe, J. , Catalan, A. , Retamal, D. , Escobar, J.A. and Madrid, E.M. (2006) Oxidative stress is closely related to clinical severity of pre-eclampsia . Biol Res39: 229-236.
12.
Chesley, L.C. (1972) Plasma and red cell volumes during pregnancy . Am J Obstet Gynecol112: 440-450.
13.
Cockell, A.P. and Poston, L. (1997) Flow-mediated vasodilatation is enhanced in normal pregnancy but reduced in preeclampsia . Hypertension30: 247-251.
14.
Conrad, K.P. , Kerchner, L.J. and Mosher, M.D. (1999) Plasma and 24-h NO(x) and cGMP during normal pregnancy and preeclampsia in women on a reduced NO(x) diet . Am J Physiol277: F48-F57.
15.
D'Anna, R. , Baviera, G. , Corrado, F. , Crisafulli, A. , Ientile, R. , Buemi, M. et al. (2004) Neurokinin B and nitric oxide plasma levels in pre-eclampsia and isolated intrauterine growth restriction . BJOG111: 1046-1050.
16.
Davidge, S.T. , Stranko, C.P. and Roberts, J.M. (1996) Urine but not plasma nitric oxide metabolites are decreased in women with preeclampsia . Am J Obstet Gynecol174: 1008-1013.
17.
Dechend, R. , Homuth, V. , Wallukat, G. , Kreuzer, J. , Park, J.K. , Theuer, J. et al. AT(1) receptor agonistic antibodies from preeclamptic patients cause vascular cells to express tissue factor . Circulation101: 2382-2387.
18.
Deng, A. , Engels, K. and Baylis, C. (1996) Impact of nitric oxide deficiency on blood pressure and glomerular hemodynamic adaptations to pregnancy in the rat . Kidney Int50: 1132-1138.
19.
Diedrich, F. , Renner, A. , Rath, W. , Kuhn, W. and Wieland, E. (2001) Lipid hydroperoxides and free radical scavenging enzyme activities in preeclampsia and HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome: no evidence for circulating primary products of lipid peroxidation . Am J Obstet Gynecol185: 166-172.
20.
Diejomaoh, F.M. , Omu, A.E. , Al Busiri, N. , Taher, S. , Al Othman, S. , Fatinikun, T. et al. (2004) Nitric oxide production is not altered in preeclampsia . Arch Gynecol Obstet269: 237-243.
21.
Dorup, I. , Skajaa, K. and Sorensen, K.E. (1999) Normal pregnancy is associated with enhanced endothelium-dependent flow-mediated vasodilation . Am J Physiol276: H821-H825.
22.
Egerman, R.S. , Andersen, R.N. , Manejwala, F.M. and Sibai, B.M. (1999) Neuropeptide Y and nitrite levels in preeclamptic and normotensive gravid women . Am J Obstet Gynecol181: 921-923.
23.
Ellis, J. , Wennerholm, U.B. , Bengtsson, A. , Lilja, H. , Pettersson, A. , Sultan, B. et al. (2001) Levels of dimethylarginines and cytokines in mild and severe preeclampsia . Acta Obstet Gynecol Scand80: 602-608.
24.
Facchinetti, F. , Longo, M. , Piccinini, F. , Neri, I. and Volpe, A. (1999) L-Arginine infusion reduces blood pressure in preeclamptic women through nitric oxide release . J Soc Gynecol Invest6: 202-207.
25.
Facchinetti, F. , Saade, G.R. , Neri, I. , Pizzi, C. , Longo, M. and Volpe, A. (2007) L-arginine supplementation in patients with gestational hypertension: a pilot study . Hypertens Preg26: 121-130.
26.
Felix, C. , Lopez, A. , Delgado, F. , Amores, E. , Narvaez, M. and Lopez-Jaramillo, P. (1991) Vascular prostacyclin production in Andean women with pregnancy-induced hypertension . Braz J Med Biol Res24: 59-62.
27.
Fickling, S.A. , Williams, D. , Vallance, P. , Nussey, S.S. and Whitley, G.S. (1993) Plasma concentrations of endogenous inhibitor of nitric oxide synthesis in normal pregnancy and pre-eclampsia . Lancet342: 242-243.
28.
Garcia, R.G. , Celedon, J. , Sierra-Laguado, J. , Alarcon, M.A. , Luengas, C. , Silva, F. et al. (2007) Raised C-reactive protein and impaired flow-mediated vasodilation precede the development of preeclampsia . Am J Hypertens20: 98-103.
29.
Gilbert, J.S. , Ryan, M.J. , La Marca, B.B. , Sedeek, M.H. , Murphy, S.R. and Granger, J.P. (2007) Pathophysiology of hypertension during preeclampsia: linking placental ischemia with endothelial dysfunction . Am J Physiol Heart Circ Physiol294: H541-H550.
30.
Hata, T. , Hashimoto, M. , Kanenishi, K. , Akiyama, M. , Yanagihara, T. and Masumura, S. (1999) Maternal circulating nitrite levels are decreased in both normal normotensive pregnancies and pregnancies with preeclampsia . Gynecol Obstet Invest48: 93-97.
31.
Heilmann, L. (1987) Blood rheology and pregnancy . Baillieres Clin Haematol1: 777-799.
32.
Herrera, J.A. , Arevalo-Herrera, M. , Shahabuddin, A.K. , Ersheng, G. , Herrera, S. , Garcia, R.G. et al. (2006) Calcium and conjugated linoleic acid reduces pregnancy-induced hypertension and decreases intracellular calcium in lymphocytes . Am J Hypertens19: 381-387.
33.
Herrera, J.A. , Chaudhuri, G. and Lopez-Jaramillo, P. (2001) Is infection a major risk factor for preeclampsia ? Med Hypotheses57: 393-397.
34.
Herrera, J.A. , Parra, B. , Herrera, E. , Botero, J.E. , Arce, R.M. , Contreras, A. et al. (2007) Periodontal disease severity is related to high levels of C-reactive protein in pre-eclampsia . J Hypertens25: 1459-1464.
35.
Herrera, J.A. , Shahabuddin, A.K. , Ersheng, G. , Wei, Y. , Garcia, R.G. and Lopez-Jaramillo, P. (2005) Calcium plus linoleic acid therapy for pregnancy-induced hypertension . Int J Gynaecol Obstet91: 221-227.
36.
Hill, J.A. , Devoe, L.D. and Bryans Jr, C.I. (1986) Frequency of asymptomatic bacteriuria in preeclampsia . Obstet Gynecol67: 529-532.
37.
Holden, D.P. , Fickling, S.A. , Whitley, G.S. and Nussey, S.S. (1998) Plasma concentrations of asymmetric dimethylarginine, a natural inhibitor of nitric oxide synthase, in normal pregnancy and preeclampsia . Am J Obstet Gynecol178: 551-556.
38.
Joffe, G.M. , Esterlitz, J.R. , Levine, R.J. , Clemens, J.D. , Ewell, M.G. , Sibai, B.M. et al. (1998) The relationship between abnormal glucose tolerance and hypertensive disorders of pregnancy in healthy nulliparous women. Calcium for Preeclampsia Prevention (CPEP) Study Group . Am J Obstet Gynecol179: 1032-1037.
39.
Kharb, S. (2000) Low whole blood glutathione levels in pregnancies complicated by preeclampsia and diabetes . Clin Chim Acta294: 179-183.
40.
Kovasc, A.G. , Makary, A. , Peto, J. and Steinmetz, G. (1994) Deficiency of cGMP level in placental circulation in pregnancy-induced hypertensive disorders: possibility of decreased endothelium-derived relaxing factor . Hypertens Pregn13: 163-169.
41.
Kuzkaya, N. , Weissmann, N. , Harrison, D.G. and Dikalov, S. (2003) Interactions of peroxynitrite, tetrahydrobiopterin, ascorbic acid, and thiols: implications for uncoupling endothelial nitric-oxide synthase . J Biol Chem278: 22546-22554.
42.
Lees, M.M. , Taylor, S.H. , Scott, D.B. and Kerr, M.G. (1974) A study of cardiac output at rest throughout pregnancy . J Obstet Gynaecol Br Commonw74: 319-328.
43.
Levine, R.J. , Maynard, S.E. , Quian, C. , Lim, K.H. , England, L.J. , Yu, K.F. et al. (2004) Circulating angiogenic factors and the risk of preeclampsia . N Engl J Med350: 672-683.
44.
Li, H. , Meininger, C.J. , Hawker Jr, J.R. , Haynes, T.E. , Kepka-Lenhart, D. , Mistry, S.K. et al. (2001) Regulatory role of arginase I and II in nitric oxide, polyamine, and proline syntheses in endothelial cells . Am J Physiol Endocrinol Metab280: E75-82.
45.
Li, N. and Karin, M. (1999) Is NF-kappaB the sensor of oxidative stress ? FASEB J13: 1137-1143.
46.
Lopez-Jaramillo, P. (1996) Prevention of preeclampsia with calcium supplementation and its relation with the L-arginine:nitric oxide pathway . Braz J Med Biol Res29: 731-741.
47.
López-Jaramillo, P. (2000) Calcium, nitric oxide and preclampsia . Sem Perinatol24: 33-36.
48.
Lopez-Jaramillo, P. , Casas, J.P. and Serrano, N. (2001) Preeclampsia: from epidemiological observations to molecular mechanisms . Braz J Med Biol Res34: 1227-1235.
49.
Lopez-Jaramillo, P. , Delgado, F. , Jacome, P. , Teran, E. , Ruano, C. and Rivera, J. (1997) Calcium supplementation and the risk of preeclampsia in Ecuadorian pregnant teenagers . Obstet Gynecol90: 162-167.
50.
Lopez-Jaramillo, P. , García, R. and Silva, F. (2005) Asymetric Dimethylarginine (ADMA): patophysiological reality or biological curiosity. In Hernandez-Hernandez, R.,Armas-Hernandez, M. (ed.), Current advances in hypertension, EditorialMonduzzi : Bologna, pp. 57-62.
51.
Lopez-Jaramillo, P. , Garcia, R.G. and Lopez, M. (2005) Preventing pregnancy-induced hypertension: are there regional differences for this global problem ? J Hypertens23: 1121-1129.
52.
Lopez-Jaramillo, P. , Gonzalez, M.C. , Palmer, R.M. and Moncada, S. (1990) The crucial role of physiological Ca2+ concentrations in the production of endothelial nitric oxide and the control of vascular tone . Br J Pharmacol101: 489-493.
53.
Lopez-Jaramillo, P. , Narvaez, M. , Calle, A. , Rivera, J. , Jacome, P. , Ruano, C. et al. (1996) Cyclic guanosine 3',5' monophosphate concentrations in pre-eclampsia: effects of hydralazine . Br J Obstet Gynaecol103: 33-38.
54.
Lopez-Jaramillo, P. , Narvaez, M. , Felix, C. and Lopez, A. (1990) Dietary calcium supplementation and prevention of pregnancy hypertension . Lancet335: 293 .
55.
Lopez-Jaramillo, P. , Narvaez, M. , Felix, C. , Sosa, C. , Calle, A. , Nava, E. et al. (1992) Decreased nitric oxide synthesis in Andean Ecuadorian women with pregnancy-induced hypertension. Biology of nitric oxide , Portland Press: London, p. 376.
56.
Lopez-Jaramillo, P. , Narvaez, M. , Weigel, R.M. and Yepez, R. (1989) Calcium supplementation reduces the risk of pregnancy-induced hypertension in an Andes population . Br J Obstet Gynaecol96: 648-655.
57.
Lopez-Jaramillo, P. , Teran, E. and Moncada, S. (1995) Calcium supplementation prevents pregnancy-induced hypertension by increasing the production of vascular nitric oxide . Med Hypotheses45: 68-72.
58.
López-Jaramillo, P. , Teran, E. , Ringgvist, A. , Moya, W. , Rivera, J. and Berrazueta, J.R. (1998) Oxidised low-density lipoproteins and nitric oxide during normal pregnancy and preeclampsia. In Moncada, S.,Toda, N.,Maeda, H.,Higgs, E.A. (ed.), Biology of nitric oxide, Part 6. Portland Press: London, p. 322.
59.
Lowe, D.T. (2000) Nitric oxide dysfunction in the pathophysiology of preeclampsia . Nitric Oxide4: 441-458.
60.
Lund, C.J. and Donovan, J.C. (1967) Blood volume during pregnancy. Significance of plasma and red cell volumes . Am J Obstet Gynecol98: 394-403.
61.
Maas, R. , Boger, R.H. , Schwedhelm, E. , Casas, J.P. , Lopez-Jaramillo, P. , Serrano, N. et al. (2004) Plasma concentrations of asymmetric dimethylarginine (ADMA) in Colombian women with pre-eclampsia . JAMA291: 823-824.
62.
Madazli, R. , Benian, A. , Gumustas, K. , Uzun, H. , Ocak, V. and Aksu, F. (1999) Lipid peroxidation and antioxidants in preeclampsia . Eur J Obstet Gynecol Reprod Biol85: 205-208.
63.
Makkonen, N. , Heinonen, S. , Hongisto, T. , Penttila, I. and Kirkinen, P. (2002) Normalization of vasoactive changes in preeclampsia precedes clinical recovery . Hypertens Pregnancy21: 51-64.
64.
Many, A. , Hubel, C.A. , Fisher, S.J. , Roberts, J.M. and Zhou, Y. (2000) Invasive cytotrophoblasts manifest evidence of oxidative stress in preeclampsia . Am J Pathol156: 321-331.
65.
Maynard, S.E. , Min, J.Y. , Merchan, J. , Lim, K.H. , Li, J. , Mondal, S. et al. (2003) Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia . J Clin Invest111: 649-658.
66.
McCord, N. , Ayuk, P. , McMahon, M. , Boyd, R.C. , Sargent, I. and Redman, C. (2006) System y+ arginine transport and NO production in peripheral blood mononuclear cells in pregnancy and preeclampsia . Hypertension47: 109-115.
67.
Metcalfe, J. and Ueland, K. (1974) Maternal cardiovascular adjustments to pregnancy . Prog Cardiovasc Dis16: 363-374.
68.
Moncada, S. , Higgs , Hodson, H.F. , Knowles, R.G. , López-Jaramillo, P. , McCall , T. et al. (1991) The L-arginine: nitric oxide pathway . Journal of Cardiovascular Pharmacology17: s1-s9.
69.
Moutquin, J.M. , Rainville, C. , Giroux, L. , Raynauld, P. , Amyot, G. , Bilodeau, R. et al. (1985) A prospective study of blood pressure in pregnancy: prediction of preeclampsia . Am J Obstet Gynecol151: 191-196.
70.
Mutlu-Turkoglu, U. , Aykac-Toker, G. , Ibrahimoglu, L. , Ademoglu, E. and Uysal, M. (1999) Plasma nitric oxide metabolites and lipid peroxide levels in preeclamptic pregnant women before and after delivery . Gynecol Obstet Invest48: 247-250.
71.
Myatt, L. and Cui, X. (2004) Oxidative stress in the placenta . Histochem Cell Biol122: 369-382.
72.
Myatt, L. , Rosenfield, R.B. , Eis, A.L.W. , Brockman, D.E. , Greer, I. and Lyall, F. (1996) Nitrotyrosine residues in placenta. Evidence of peroxynitrite formation and action . Hypertension28: 488-493.
73.
Neri, I. , Marietta, M. , Piccinini, F. , Volpe, A. and Facchinetti, F. (1998) The L-arginine-nitric oxide system regulates platelet aggregation in pregnancy . J Soc Gynecol Invest5: 192-196.
74.
Neri, I. , Mazza, V. , Galassi, M.C. , Volpe, A. and Facchinetti, F. (1996) Effects of L-arginine
75.
on utero-placental circulation in growth-retarded fetuses . Acta Obstet Gynecol Scand75: 208-212.
76.
Neri, I. , Piccinini, F. , Marietta, M. , Facchinetti, F. and Volpe, A. (2000) Platelet responsiveness to L-arginine in hypertensive disorders of pregnancy . Hypertens Pregnancy19: 323-330.
77.
Nishikawa, S. , Miyamoto, A. , Yamamoto, H. , Ohshika, H. and Kudo R. (2000) The relationship between serum nitrate and endothelin-1 concentrations in preeclampsia . Life Sci67: 1447-1454.
78.
Noris, M. , Perico, N. and Remuzzi, G. (2005) Mechanisms of disease: pre-eclampsia . Nat Clin Pract Nephrol1: 98-114.
79.
Noris, M. , Todeschini, M. , Cassis, P. , Pasta, F. , Cappellini, A. , Bonazzola, S. et al. (2004) L-arginine depletion in preeclampsia orients nitric oxide synthase toward oxidant species . Hypertension43: 614-622.
80.
Norris, L.A. , Higgins, J.R. , Darling, M.R. , Walshe, J.J. and Bonnar, J. (1999) Nitric oxide in the uteroplacental, fetoplacental, and peripheral circulations in preeclampsia . Obstet Gynecol93: 958-963.
81.
Pasaoglu, H. , Bulduk, G. , Ogus, E. , Pasaoglu, A. and Onalan, G. (2004) Nitric oxide, lipid peroxides, and uric acid levels in pre-eclampsia and eclampsia . Tohoku J Exp Med202: 87-92.
82.
Radi, R. , Beckman, J.S. , Bush, K.M. and Freeman, B.A. (1991) Peroxynitrite-induced membrane lipid peroxidation: the cytotoxic potential of superoxide and nitric oxide . Arch Biochem Biophys288: 481-487.
83.
Ranta, V. , Viinikka, L. , Halmesmaki, E. and Ylikorkala, O. (1999) Nitric oxide production with preeclampsia . Obstet Gynecol93: 442-445.
84.
Ronson, R.S. , Nakamura, M. and Vinten-Johansen, J. (1999) The cardiovascular effects and implications of peroxynitrite . Cardiovasc Res44: 47-59.
85.
Rumbold, A. , Duley, L. , Crowther, C. and Haslam, R. (2007) Antioxidants for preventing pre-eclampsia (Cochrane Review). In The Cochrane Library, Issue 4, Update Software: Oxford .
86.
Saarelainen, H. , Laitinen, T. , Raitakari, O.T. , Juonala, M. , Heiskanen, N. , Lyyra-Laitinen, T. et al.
87.
( 2006) Pregnancy-related hyperlipidemia and endothelial function in healthy women . Circ J70: 768-772.
88.
Sagol, S. , Ozkinay, E. and Ozsener, S. (1999) Impaired antioxidant activity in women with pre-eclampsia . Int J Gynaecol Obstet64: 121-127.
89.
Sankaraligam, S. , Arenas, I.A. , Lalu, M.M. and Davidge, S.T. (2006) Preeclampsia: current understanding of the molecular basis of vascular dysfunction . Expert Rev Mol Med8: 1-20.
90.
Savvidou, M.D. , Hingorani, A.D. , Tsikas, D. , Frolich, J.C. , Vallance, P. and Nicolaides, K.H. (2003) Endothelial dysfunction and raised plasma concentrations of asymmetric dimethylarginine in pregnant women who subsequently develop pre-eclampsia . Lancet361: 1511-1517.
91.
Savvidou, M.D. , Kametas, N.A. , Donald, A.E. and Nicolaides, K.H. (2000) Non-invasive assessment of endothelial function in normal pregnancy . Ultrasound Obstet Gynecol15: 502-507.
92.
Schiessl, B. , Strasburger, C. , Bidlingmaier, M. , Mylonas, I. , Jeschke, U. , Kainer, F. et al. (2006) Plasma- and urine concentrations of nitrite/nitrate and cyclic Guanosinemonophosphate in intrauterine growth restricted and preeclamptic pregnancies . Arch Gynecol Obstet274: 150-154.
93.
Schneider, F. , Lutun, P. , Baldauf, J.J. , Quirin, L. , Dreyfus, M. , Ritter, J. et al. (1996) Plasma cyclic GMP concentrations and their relationship with changes of blood pressure levels in pre-eclampsia . Acta Obstet Gynecol Scand75: 40-44.
94.
Seligman, S.P. , Buyon, J.P. , Clancy, R.M. , Young, B.K. and Abramson, S.B. (1994) The role of nitric oxide in the pathogenesis of preeclampsia . Am J Obstet Gynecol171: 944-948.
95.
Serdar, Z. , Gur, E. , Develioglu, O. , Colakogullari, M. and Dirican, M. (2002) Placental and decidual lipid peroxidation and antioxidant defenses in preeclampsia. Lipid peroxidation in preeclampsia . Pathophysiology9: 21-25.
96.
Serrano, N.C. , Casas, J.P. , Diaz, L.A. , Paez, C. , Mesa, C.M. , Cifuentes, R. et al. (2004) Endothelial NO synthase genotype and risk of preeclampsia: a multicenter case-control study . Hypertension44: 702-707.
97.
Shaamash, A.H. , Elsnosy, E.D. , Makhlouf, A.M. , Zakhari, M.M. , Ibrahim, O.A. and EL dien, H.M. (2000) Maternal and fetal serum nitric oxide (NO) concentrations in normal pregnancy, pre-eclampsia and eclampsia . Int J Gynaecol Obstet68: 207-214.
98.
Sharma, J.B. , Sharma, A. , Bahadur, A. , Vimala, N. , Satyam, A. and Mittal, S. (2006) Oxidative stress markers and antioxidant levels in normal pregnancy and pre-eclampsia . Int J Gynaecol Obstet94: 23-27.
99.
Sierra-Laguado, J. , Garcia, R.G. and Lopez-Jaramillo, P. (2006) Flow-mediated dilatation of the brachial artery in pregnancy . Int J Gynaecol Obstet93: 60-61.
100.
Sierra-Laguado, J. , Garcia, R.G. , Celedon, J. , Arenas-Mantilla, M. , Pradilla, L.P. , Camacho, P.A. et al. (2007) Determination of insulin resistance using the homeostatic model assessment (HOMA) and its relation with the risk of developing pregnancy-induced hypertension . Am J Hypertens20: 437-442.
101.
Silver, R.K. , Kupferminc, M.J. , Russell, T.L. , Adler, L. , Mullen, T.A. and Caplan, M.S. (1996) Evaluation of nitric oxide as a mediator of severe preeclampsia . Am J Obstet Gynecol175: 1013-1017.
102.
Sladek, S.M. , Magness, R.R. and Conrad, K.P. (1997) Nitric oxide and pregnancy . Am J Physiol272: R441-R463.
103.
Slaghekke, F. , Dekker, G. and Jeffries, B. (2006) Endogenous inhibitors of nitric oxide and preeclampsia: a review . J Matern Fetal Neonatal Med19: 447-452.
104.
Staff, A.C. , Berge, L. , Haugen, G. , Lorentzen, B. , Mikkelsen, B. and Henriksen, T. (2004) Diettary supplementation with L-arginine or placebo in women with pre-eclampsia . Acta Obstet Gynecol Scand83: 103-107.
105.
Steinert, J.R. , Wyatt, A.W. , Poston, L. , Jacob, R. and Mann, G.E. (2002) Preeclampsia is associated with altered Ca2+ regulation and NO production in human fetal venous endothelial cells . FASEB J16: 721-723.
106.
Takata, M. , Nakatsuka, M. and Kudo, T. (2002) Differential blood flow in uterine, ophthalmic, and brachial arteries of preeclamptic women . Obstet Gynecol100: 931-939.
107.
Taylor, D.J. and Lind, T. (1979) Red cell mass during and after normal pregnancy . Br J Obstet Gynaecol86: 364-370.
108.
Teran, E. , Escudero, C. and Moya, W. (2006) Abnormal release of nitric oxide from nitrosoprotein in preeclampsia . Int J Gynaecol Obstet92: 260-261.
109.
Teran, E. , Escudero, C. , Vivero, S. , Enriquez, A. and Calle, A. (2004) Intraplatelet cyclic guanosine-3',5'-monophosphate levels during pregnancy and preeclampsia . Hypertens Pregnancy23: 303-308.
110.
Toth, M. (2002) Role of tetrahydrobiopterin in the regulation of activity of human placental nitric oxide synthase in normal and pre-eclamptic pregnancies . Orv Hetil143: 391-398.
111.
Trogstad, L.I. , Eskild, A. , Bruu, A.L. , Jeansson, S. and Jenum, P.A. (2001) Is preeclampsia an infectious disease ? Acta Obstet Gynecol Scand80: 1036-1038.
112.
Var, A. , Yildirim, Y. , Onur, E. , Kuscu, N.K. , Uyanik, B.S. , Goktalay, K. et al. (2003) Endothelial dysfunction in preeclampsia. Increased homocysteine and decreased nitric oxide levels . Gynecol Obstet Invest56: 221-224.
113.
Venkatesha, S. , Toporsian, M. , Lam, C. , Hanai, J. , Mammoto, T. , Kim,Y.M. et al. (2006) Soluble endoglin contributes to the pathogenesis of preeclampsia . Nat Med12: 642-649.
114.
Vural, P. (2002) Nitric oxide/endothelin-1 in preeclampsia . Clin Chim Acta317: 65-70.
Williams, D.J. , Vallance, P.J. , Neild, G.H. , Spencer, J.A. and Imms, F.J. (1997) Nitric oxide-mediated vasodilation in human pregnancy . Am J Physiol272: H748-H752.
117.
World Health Organization (2004) Maternal mortality in 2000: estimates developed by WHO, UNICEF and UNFPA.
118.
World Health Organization International Collaborative Study of Hypertensive Disorders of Pregnancy (1988) Geographic variation in the incidence of hypertension in pregnancy . Am J Obstet Gynecol158: 80-83.
119.
World Health Organization. (1987) Technical Reports Series. The hypertensive disorders of pregnancy, Geneve .
120.
Xia,Y. , Dawson, V.L. , Dawson, T.M. , Snyder, S.H. amd Zweier, J.L. (1996) Nitric oxide synthase generates superoxide and nitric oxide in arginine-depleted cells leading to peroxynitritemediated cellular injury . Proc Natl Acad Sci USA93: 6770-6774.
121.
Xia, Y. , Wen, H. , Bobst, S. , Day, M.C. and Kellems, R.E. (2003) Maternal autoantibodies from preeclamptic patients activate angiotensin receptors on human trophoblast cells . J Soc Gynecol Investig10: 82-93.
122.
Xiang, W. , Chen, H. , Xu, X. , Zhang, M. and Jiang, R. (2005) Expression of endothelial nitric oxide synthase traffic inducer in the placentas of women with pre-eclampsia . Int J Gynaecol Obstet89: 103-107.
123.
Yamamoto, T. , Suzuki, Y. , Kojima, K. and Suzumori, K. (2005) Reduced flow-mediated vasodilation is not due to a decrease in production of nitric oxide in preeclampsia . Am J Obstet Gynecol192: 558-563.
124.
Yanik, F.F. , Amanvermez, R. , Kocak, I. , Yanik, A. and Celik, C. (2001) Serum nitric oxide and glutathione levels in preeclamptic and normotensive women during labor . Gynecol Obstet Invest51: 110-115.
125.
Yao, D. , Vlessidis, A.G. and Evmiridis, N.P. (2004) Determination of nitric oxide in biological samples . Microchimica Acta147: 1-20.
126.
Yoneyama, Y. , Suzuki, S. , Sawa, R. , Miura, A. , Doi, D. , Otsubo, Y. et al. (2002) Plasma nitric oxide levels and the expression of P-selectin on platelets in preeclampsia . Am J Obstet Gynecol187: 676-680.
127.
Yoshida, A. , Nakao, S. , Kobayashi, M. and Kobayashi, H. (2000) Flow-mediated vasodilation and plasma fibronectin levels in preeclampsia . Hypertension36: 400-404.
